STUDY OF CLINICAL PRESENTATION, IMAGING, PATHOLOGICAL PROFILE AND MANAGEMENT OF BENIGN BREAST CONDITION IN TERTIARY HEALTH CARE CENTRE

Background: Benign breast diseases (BBDs) are not life threatening clinicians require a thorough knowledge so that clear explanations can be given to patients and appropriate treatment can be instituted, and unnecessary long term follow up can be avoided. Present study was aimed to study clinical presentation, imaging, pathological profile and management of benign breast condition in a tertiary health care center.

Material and Methods: Present study was descriptive, cross-sectional study, conducted in females, age >10 years with benign breast diseases.

Results: Among 215 cases, majority were from the age group of 21-30 years (52.56%), followed by in 31-40 years (21.39%). The mean age among the distribution of cases was 28.16 ±10.12 years. 173 (80.47%) were in premenopausal status, followed by 42 (19.53%) of postmenopausal status. All cases were presented with breast lump (100%), along with lump pain was seen in 45 (20.93%) cases and nipple discharge in 37(17.21%) cases. Majority had unilateral lump (84.1%) ,in right upper outer quadrant (23.08%), followed by left upper outer quadrant (21.53%). The maximum number of cases had size of 2-5 cm (53.02%), followed by <2 cm (32.09%) and only 14.89% cases had size >5 cm. Out of 215 cases of benign breast diseases, benign neoplasms (Fibroadenoma, Benign phylloides, Intraductal Papilloma)comprising of 68% of cases and benign lesions (Inflammatory, Fibroadenosis, Fibrocystic diseases, Galactocele) were 32% of cases. Fibroadenoma was the commonest of all benign neoplasms (63.26%) followed by benign phylloides (3.26%).179 (83.26%) were lumpectomies, 21 (9.77%) was Incisional biopsies and 11 (5.58%) were simple mastectomies.

Conclusion: Fibroadenoma is the most common benign breast disease affecting women in their reproductive age group. Triple assessment provided quick diagnosis and it alleviated unnecessary anxiety from patients about breast cancer.